Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar
Martina Kovarova, PhD
Associate Professor
Division of Infectious Diseases, School of Medicine
University of North Carolina at Chapel Hill
Dr. Martina Kovarova, Ph.D. is an Associate Professor in the Department of Medicine, Division of Infectious Diseases at the University of North Carolina, School of Medicine. She received her Ph.D. at the 1st Faculty of Medicine, Charles University, Prague, and post-doctoral training at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
The main interest of Dr. Kovarova’s research is focused on the development of long-acting formulations for treatment and prevention of HIV, TB, and other infectious diseases. This includes nanoparticles, nanosuspensions, and In Situ Forming Implants (ISFI) technology. In addition, Dr. Kovarova has expertise in a field of preclinical evaluation of new HIV treatment strategies using humanized mice.
The May TRAC Seminar Series is presented by the Pharmacology and Pharmacometrics Core.
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar
Rob Christiaan van Wijk, PhD
Department of Bioengineering and Therapeutic Sciences
University of California San Francisco
The May TRAC Seminar Series is presented by the Pharmacology and Pharmacometrics Core.
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar
The TRAC MIAMI Core is pleased to host Dr. Ong for a special Visiting Faculty Seminar during the TRAC Seminar Series.
Dr Catherine ONG PhD FAMS FRCP
Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, NUS
Principal Investigator, Institute for Health Innovation & Technology (iHealthtech)
Principal Investigator and Primary Member, Infectious Diseases Translational Research Programme
Senior Consultant, Division of Infectious Diseases, National University Hospital
Visiting Consultant, Tuberculosis Control Unit
Dr Catherine W.M. ONG MBBS MRCP(UK) MMed (Int Med) PhD FAMS FRCP is an Assistant Professor with the Department of Medicine at the Yong Loo Lin School of Medicine, Principal Investigator in iHealthtech NUS, Senior Consultant with the Division of Infectious Diseases in the National University Hospital and Visiting Consultant at the Singapore Tuberculosis Control Unit with both research and clinical interests in Tuberculosis. She serves in international journal editorial boards; as Associate Editor of the leading European Respiratory Journal, and Deputy Editor of the flagship International Journal of Tuberculosis and Lung Diseases. Her other portfolios include: Secretary to the ESCMID Study Group for Mycobacterial Infections (ESGMYC) and Vice-President of the Society of Infectious Disease (Singapore) in service of national and international societies.
Catherine graduated in medicine from NUS and during Infectious Diseases specialist training completed a full-time PhD at Imperial College London funded by the National Medical Research Council (NMRC) on the competitive National Research Foundation – Ministry of Health Scholarship. Her laboratory focuses on Tuberculosis host-pathogen interactions and TB host-directed therapies in multi-national clinical trials. Her works are published in top journals such as the Lancet Infectious Diseases, ERJ and the Journal of Clinical Investigation. Work is funded by the NMRC, Institut-Merieux, National Centre for Infectious Diseases and NUS with grant income as sole-PI of over SGD $10 million. Her students and research staff have won multiple national/international-level awards.
On clinical aspects of TB, Catherine serves the Ministry of Health Singapore, and works with WHO Coordinating Centres and WHO itself. For her work in tuberculosis, she received multiple national and international accolades. They include a Presidential Award prize at the American Society for Leukocyte Biology 2011, Keystone Symposia Global Health Travel Award by Bill and Melinda Gates Foundation 2012, International Investigator Award by the Infectious Diseases Society of America 2013, NMRC Transition Award 2015, Institut Merieux-SIDS Young Investigator Award 2018 and NMRC Clinician Scientist Award 2018 with successful renewal in 2022.
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar
Janice K Louie, MD, MPH
Medical Director, San Francisco Department of Public Health Tuberculosis Prevention and Control Program
Assistant Clinical Professor in the University of California San Francisco Department of Medicine
Dr. Janice Louie is Medical Director of the San Francisco Department of Public Health Tuberculosis Prevention and Control Program, and Assistant Clinical Professor in the University of California San Francisco Department of Medicine where she performs Infectious Disease Consultation. Her primary focus is to ensure continued excellence in the clinical management of tuberculosis, provide mentorship and training to fellows, residents and other trainees, and advancing clinical practices in tuberculosis with a focus on the elderly.
The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar
Nicholas Paton, MD, FRCP
Professor of Infectious Diseases, National University of Singapore
Professor of Infectious Diseases, London School of Hygiene and Tropical Medicine
Prof. Nicholas Paton trained in Medicine and Infectious Diseases in Cambridge, Sydney and London, and in Epidemiology at the London School of Hygiene and Tropical Medicine. From 1997 to 2005 he worked as Head of Department at the National HIV Referral Centre in Singapore and, in addition to clinical care responsibilities, developed a Centre for Research in HIV and Communicable Diseases. From 2006 to 2011 he worked at the UK MRC Clinical Trials Unit where he was the Chief Investigator of large HIV treatment trials such as PIVOT (a trial of a PI-monotherapy strategy done at 45 clinical sites in the UK); and EARNEST (testing options for second-line therapy in over 1200 patients in 5 countries in sub-Saharan Africa).
He currently holds a joint appointment as Professor of Infectious Diseases at the National University of Singapore and at the London School of Hygiene and Tropical Medicine. He is the Chief Investigator of the NADIA trial (comparing dolutegravir with darunavir and comparing maintenance of tenofovir versus switching to zidovudine in second-line therapy, done in 7 sites in Uganda, Kenya and Zimbabwe) and the scientific lead of the CARES trial (comparing long acting cabotegravir/rilpivirine with standard combination ART at 8 sites in Uganda, Kenya and South Africa). In Singapore he leads a programme of TB trials focused on trials of host-directed therapies for TB and exploring novel TB trial outcome measures; and is the Chief Investigator on the TRUNCATE-TB trial (a strategy trial of 2 months of treatment for drug-susceptible TB done across a network of 18 sites in Asia and Africa).
The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom | Add to Calendar
Jyoti S. Mathad, MD, MSc
Assistant Professor, Department of Medicine and Obstetrics & Gynecology, Weill Cornell Medical College
JHU Center for Clinical Global Health Education
Johns Hopkins Center for Infectious Diseases Research in India
Dr. Mathad is an Assistant Professor of Medicine and Obstetrics & Gynecology in the Center for Global Health at Weill Cornell Medicine. She is also a faculty member at the Johns Hopkins Center for Clinical Global Health Education. Her primary research interests include the immune and metabolic changes of pregnancy and their impact on the pathogenesis of infectious diseases such as tuberculosis (TB). She has been conducting NIH-funded research in Pune, India since 2010, leading the PRACHITi study on the impact of stage of pregnancy and HIV on the immune response to M. tuberculosis, an R21 on the impact of HIV on placental immunology, and most recently the PRAGaTHI study on the intersection of HIV, TB and gestational diabetes. An active member of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials network (IMPAACT), Dr. Mathad chaired the only study of the safety, tolerability and pharmacokinetics of the 3-month isoniazid/rifapentine regimen for latent TB treatment in pregnant and postpartum women (IMPAACT 2001) and will chair an upcoming trial on 1HP and 3HP in pregnant people living with HIV in South Africa.
In addition to her innovative research, Dr. Mathad also devotes considerable time to mentoring students, residents, and fellows interested in global health, both in New York and India. She co-leads the Women in Global Health Research Initiative at Weill Cornell.
The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar.
Laurence BORAND, PharmD, PhD
Associate Professor of Medicine
Center for Tuberculosis Research
Johns Hopkins University School of Medicine
Dr Laurence Borand is a PharmD and Epidemiologist specialized in Clinical Research. She recently joined the Center for TB Research as Director of the Clinical Operations for the SMART4TB project. She used to stand as Head of the Clinical Research Group for the Institut Pasteur International Network. She worked in Clinical Research in several South-East Asian countries in collaboration with African countries over the last years and contributed to impactful multicentric trials/studies on TB prevention, diagnosis and care.
The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953
Add to Calendar
Styliani Karanika, MD
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Dr. Karanika is an Infectious Disease physician and Assistant Professor of Medicine. Her research focuses on TB immunology and host-directed therapies, with a special interest in therapeutic TB vaccines.
The March TRAC Seminar Series is presented by the Microbiology, Immunology, Animal Modeling and Imaging Core on “The host in TB drug development.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953
Eileen Scully, MD, PhD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Dr. Scully is an Infectious Disease physician primarily focused on the care of people living with HIV and an immunologist. Her research focuses on the innate immune system in the immunopathogenesis of infections with a special interest in the role of biological sex in shaping host responses.
The March TRAC Seminar Series is presented by the Microbiology, Immunology, Animal Modeling and Imaging Core on “The host in TB drug development.”
Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953
Anne Hamacher-Brady, PhD
Associate Scientist, Department of Molecular Microbiology and Immunology
Johns Hopkins University Bloomberg School of Public Health
The March TRAC Seminar Series is presented by the Microbiology, Immunology, Animal Modeling and Imaging Core on “Remembering the Host in TB Drug Development.”
